>>> Europe : Brokers Upgrades & Downgrades - 11th of December 2025

>>> Up
* Aker BP Raised to Outperform at RBC
* Covestro Raised to Neutral at Citi; PT 62 euros
* Delivery Hero Raised to Neutral at Cantor; PT 21.50 euros
* Elekta Raised to Buy at SEB Equities; PT 66 kronor
* Eutelsat Raised to Hold at Deutsche Bank; PT 2.30 euros
* Ferrari Raised to Outperform at BNP Paribas
* H&M Raised to Neutral at Citi; PT 172 kronor
* Kitron Raised to Buy at Pareto Securities; PT 80 kroner
* LDA SM Raised to Outperform at Renta 4; PT 1.39 euros
* Pernod Ricard Raised to Overweight at Barclays; PT 102 euros
* Rheinmetall Raised to Outperform at Bernstein; PT 2,050 euros
* Roku Raised to Buy at Jefferies; PT $135
* RS Group Raised to Overweight at JPMorgan
* Sabadell Raised to Outperform at Renta 4; PT 3.78 euros
* Sainsbury Raised to Buy at Citi; PT 349 pence
* Sainsbury Raised to Outperform at BNP Paribas; PT 375 pence
* Var Energi Raised to Overweight at JPMorgan; PT 36 kroner

>>> Down
* Aker BP Cut to Underweight at JPMorgan; PT 226 kroner
* B&M European Cut to Neutral at Citi; PT 165 pence
* Bankinter Cut to Neutral at BNP Paribas
* BAT Cut to Market Perform at Avior Capital Markets
* Clariant Cut to Neutral at Citi; PT 7.80 Swiss francs
* Delivery Hero Cut to Sell at Citi; PT 19 euros
* Evolution Cut to Neutral at Citi; PT 630 kronor
* Galp Cut to Hold at Berenberg; PT 17 euros
* Harbour Energy Cut to Neutral at JPMorgan; PT 214 pence
* Iberdrola Cut to Hold at Jefferies; PT 19.20 euros
* Lloyds Cut to Neutral at BNP Paribas
* NatWest Cut to Neutral at Goldman; PT 685 pence
* Stellantis Cut to Underperform at BNP Paribas
* Travis Perkins Cut to Sell at Deutsche Bank; PT 530 pence
* Unilever Cut to Hold at ING; PT 4,542.69 pence
* Uniqa Cut to Neutral at Oddo BHF; PT 15 euros

>>> Initiation
* Alcon AG Rated New Outperform at Oddo BHF; PT 79 Swiss francs
* Appear Rated New Buy at SB1 Markets; PT 115 kroner
* Emilshus Rated New Buy at ABG; PT 60 kronor
* Experian Resumed Overweight at JPMorgan
* Harvia Rated New Buy at Nordea; PT 48 euros
* Serco Reinstated Neutral at JPMorgan
* Systemair Rated New Buy at ABG; PT 100 kronor

>>> Call
* Alcon a Leader in Growing Markets, Oddo BHF Rates Outperform
* Chemicals Downside Now Mainly Reflected in Shares, Citi Says
* Exosens, Theon Night-Vision Order Supports Expansion: Bernstein
* Rheinmetall Raised at Bernstein, Stock Pricing In Bear Case
* Sainsbury Raised at Citi; Inditex, Tesco Among Top Retail Picks

FT : Biotech boss urges pharma to move on from ‘weight-loss Olympics’

Biotech boss urges pharma to move on from ‘weight-loss Olympics’
Zealand Pharma chief says next-generation obesity drugs will need to be longer lasting and better tolerated

Pharma companies need to move beyond the “weight-loss Olympics” and focus on more durable treatments with fewer side effects, according to the chief executive of Zealand Pharma, which this year agreed a $5.3bn obesity partnership with Roche.

Adam Steensberg, whose Copenhagen-listed group agreed the deal to develop a new weight-loss drug petrelintide in March, said the number of people who stopped using the current blockbuster drugs because of side effects represented an opportunity to offer something more tolerable.

“We need to get away from the weight-loss Olympics, which is about how fast and rapid and how deep you can go . . . We need to get into durability and quality of the weight loss,” Steensberg told the Financial Times ahead of Zealand’s capital markets day on Thursday.

Steensberg claimed data suggested 50 per cent of patients who stopped taking existing GLP-1-based weight-loss drugs did so because of side effects.

In the coming year, Zealand expects phase 2 clinical trial data for petrelintide and phase 3 data for survodutide, a drug licensed to German company Boehringer Ingelheim, which is being tested for the treatment of obesity and MASH, an associated liver disease.

Zealand’s share price has fallen nearly 30 per cent this year. Steensberg said this could be partly explained by “all the uncertainty and all the investments being made into AI” which has caused “cyclical swings” for companies like Zealand with “limited news flow”.

Petrelintide is based on the hormone amylin which makes people feel full more quickly and for longer when they eat. The most popular drugs for weight loss and type 2 diabetes currently on the market — Novo Nordisk’s Wegovy and Ozempic and Eli Lilly’s Mounjaro and Zepbound — belong to a class of medicines based on the gut hormone GLP-1, which suppresses appetite.

Studies have found that amylin-based weight-loss treatments can cause fewer side effects than GLP-1 drugs.

Steensberg said Zealand was “certain that the GLP-1s will not be able to solve the global obesity pandemic because people cannot stay on these therapies for a long run”.

With petrelintide not expected on the market until 2029, by which time generic versions of current blockbuster weight-loss drugs could also be available, Zealand’s flagship product will face stiff competition. Steensberg said he relished the challenge and drew a parallel with consumer behaviours in another market: “There are a lot of cheap used cars today, but many people still buy a new car because they want a different driving experience.”

>>> Stoxx 600 Pre-Market Indications

  • Var Energi (J4V TH) +1.7%
  • Legal & General (LGI TH) +1.5%
  • Nordex (NDX1 TH) +1.1%
  • SAP (SAP TH) -1.3%
    • Watch Software Stocks After Oracle’s Disappointing Cloud Sales
  • Hochtief (HOT TH) -1.3%
  • Leonardo (FMNB TH) -1.3%
  • Hensoldt (HAG TH) -1.3%
  • Glencore (8GC TH) -1.4%
  • Adyen (1N8 TH) -1.5%
  • ASM Intl (AVS TH) -1.5%
  • Mowi (PND TH) -1.9%
  • Alcon AG (2U3 TH) -2.3%
  • Delivery Hero (DHER TH) -4.6%
    • Delivery Hero Raised to Neutral at Cantor; PT 21.50 euros
    • Delivery Hero Cut to Sell at Citi; PT 19 euros
    • Stock up 14% yesterday

>>> TradeGate Pre-Market Indications

DAX:
  • Rheinmetall (RHM TH) +0.3%
    • Rheinmetall Raised to Outperform at Bernstein; PT 2,050 euros
  • SAP (SAP TH) -1.2%
    • Watch Software Stocks After Oracle’s Disappointing Cloud Sales
MDAX:
  • Nordex (NDX1 TH) +1.4%
  • Carl Zeiss Meditec (AFX TH) +1.3%
    • Carl Zeiss Meditec FY Revenue Beats Estimates
  • Thyssenkrupp (TKA TH) -1.1%
  • Delivery Hero (DHER TH) -4.6%
    • Delivery Hero Raised to Neutral at Cantor; PT 21.50 euros
    • Delivery Hero Cut to Sell at Citi; PT 19 euros
    • Stock up 14% yesterday
SDAX:
  • Stabilus (STM TH) +1.1%
  • Hamborner REIT (HABA TH) +1%
  • Schott Pharma AG & Co KGaA (1SXP TH) -1.3%
  • Patrizia (PAT TH) -1.8%
  • SUSS MicroTec (SMHN TH) -3.4%

>>> European Options Snapshot

Here were the Stoxx 600 companies with notable options trading:
Name Options Volume Volume vs 20D Avg. P/C Volume P/C OI Stock Move 1M IV-RV 1M IV %ile 1Y 3M 90-110 Skew %ile 1Y
Zalando 17,771 7.1 1.5 2.2 -0.7% 8.4 22 37
Aegon 97,614 6.7 1.1 1.1 -10.1% -20.5 38 19
Delivery Hero 36,465 6.4 0.0 0.6 13.7% -22.7 63 6
Essity 6,779 5.0 55.5 0.9 0.0% -0.3 5 13
Ferrari 5,329 4.5 4.6 1.3 -4.4% 0.2 47 27
SocGen 14,080 3.2 0.7 4.2 0.9% 2.5 17 28
Vonovia 29,215 2.7 1.4 1.9 -0.3% 3.6 22 96
Michelin 6,179 2.6 87.3 1.6 -0.6% 2.0 54 16
LVMH 9,005 2.6 7.1 1.1 0.4% 7.7 8 9
Enel 10,776 2.3 0.3 3.5 -0.5% -0.7 17 29


Index Options Volume Volume vs 20D Avg. P/C Volume P/C OI Index Move 1M IV-RV 1M IV %ile 1Y 3M 90-110 Skew %ile 1Y
SX5E 779,784 0.9 2.2 2.2 -0.2% 0.9 7 63
SX7E 170,704 1.3 1.0 2.2 0.2% -0.4 16 45
DAX 41,970 0.8 1.8 1.5 -0.1% 0.3 10 44
AEX 20,625 0.5 0.8 1.9 -0.4% 2.1 22 68
UKX 15,204 0.5 1.1 2.3 0.1% 1.3 33 69
SMI 12,002 0.9 1.0 1.7 -0.1% 3.0 9 55
OMX 6,855 0.5 1.1 1.8 0.1% 0.4 26 35
FTSEMIB 6,267 1.5 1.0 1.7 -0.3% 1.5 8 62
SXXP 6,124 0.5 3.9 3.9 0.1% 0.6 10 70
CAC 4,857 0.8 13.8 1.5 -0.4% 3.3 7 58
This story was produced with the assistance of Bloomberg Automation.

>>> Options Term Structure : BBVA, Prosus, Schneider Electric, Siemens Energy

  • Biggest increases in one-year vs three-month IV spread:
    • Bayer term structure up 2.2 points to 0.4, in the 88th percentile; stock rose 6.9% w/w (RSI: 78); skew in the 94th percentile
    • UniCredit term structure up 0.7 point to 1, in the 74th percentile; stock rose 2% w/w (RSI: 62); skew in the 32nd percentile
    • Intesa Sanpaolo term structure up 0.6 point to 1.5, in the 85th percentile; stock rose 0.9% w/w (RSI: 52); skew in the 38th percentile
    • Prosus term structure up 0.5 points to 4.8, in the 100th percentile; stock rose 0.3% w/w (RSI: 30); skew in the 77th percentile
    • BBVA term structure up 0.4 points to 1.2, in the 95th percentile; stock rose 1.6% w/w (RSI: 63); skew in the 40th percentile
  • Biggest decreases in one-year vs three-month IV spread:
    • BMW term structure down 1.6 points to -1.1, in the 58th percentile; stock rose 7.3% w/w (RSI: 70); skew in the 40th percentile
    • Wolters Kluwer term structure down 1.5 points to -2.3, in the 4th percentile; stock fell 2.6% w/w (RSI: 33); skew in the 20th percentile
    • Siemens Energy term structure down 1.2 points to 1.4, in the 89th percentile; stock rose 8.4% w/w (RSI: 65); skew in the 46th percentile
    • Adidas term structure down 1.1 points to 1.1, in the 84th percentile; stock rose 1% w/w (RSI: 48); skew in the 23rd percentile
    • Schneider Electric term structure down 1 points to 0.3, in the 82nd percentile; stock rose 1.7% w/w (RSI: 50); skew in the 2nd percentile

WSJ : Fed’s Fractured Vote Signals Trouble Ahead for Future Rate Cuts

Fed’s Fractured Vote Signals Trouble Ahead for Future Rate Cuts
Trump wants lower rates and a new Fed chair. Wednesday’s divisions suggest one won’t guarantee the other.

Jerome Powell pushed through a rate cut Wednesday over the broadest reservations of his nearly eight-year tenure, and in doing so, implicitly delivered a pointed message to President Trump and his own successor: Cutting rates is harder than it looks.

The decision drew three dissents—two from officials who opposed any cut and one from a Trump ally who wanted a larger reduction.

The formal vote understated the resistance. Four other officials registered a quieter objection in the Fed’s quarterly projections: They wrote down a higher interest rate for 2025 than the one the committee approved—a signal they wouldn’t have cut. Together with the dissenters, that is roughly a third of the policymakers who attend Fed meetings.


Trump immediately voiced his displeasure that the cut wasn’t bigger. “I’m looking for somebody that will be honest with interest rates,” he said on Wednesday ahead of his first formal interview with a candidate to succeed Powell, whose term ends in May. “Our rate should be much lower.”

Powell led his colleagues to cut at the past three meetings, including the one this week, based on two main considerations. First, he judged that inflation wasn’t proving to be as big a worry as many feared when Trump announced large tariff increases this past spring.

Second, while officials have expected job growth to cool gradually this year, that process has been “a touch” cooler than expected recently, he said Wednesday.

Nevertheless, Powell gave little indication that further cuts were imminent.

The Fed’s new projections underscored the challenge. Seven of 19 participants at this week’s Federal Open Market Committee meeting thought no rate cuts would be warranted next year, and four saw no more than one—likely far fewer than what the president wants, and a potential conundrum for whoever takes over in May.

Unless Trump forces major institutional upheaval, that leaves two ways he or a new chair could get lower rates next year: a much weaker economy or meaningful progress on inflation that might not be visible for months.

The division reflects a committee split over a fundamental question: not whether it could be on the brink of a policy error, but which one.

Doves see a softening labor market despite 1.5 percentage points of rate cuts over the past 15 months—now 1.75 with Wednesday’s move. They worry that waiting for proof of weakness will mean acting too late to prevent it. Hawks see a central bank cutting into an economy stronger than it looks, risking a repeat of the “stop and go” mistakes of the 1970s.

“Short of a major change in the composition of who sits around the Fed, there’s going to be enormous pushback to rate cuts,” said Diane Swonk, chief economist at KPMG.

The rate-setting Federal Open Market Committee is led by the chair but includes 11 other members: six other members of the board of governors, who are appointed by presidents from both parties, and the New York Fed president and four of 11 other Fed bank presidents, who take turns voting. Those bank presidents aren’t political appointees.

The disagreement on display reflects how the Fed was designed, said Richard Clarida, a former Fed vice chair who served alongside Powell and is now at Pimco. “The FOMC was intentionally set up to have a mix of voting on policy by the reserve bank presidents and the board,” he said. “That is very much a feature, not a bug.”

The Fed’s consensus-driven culture aims to build broad enough support to minimize dissents, but Wednesday’s opposition to a cut wasn’t necessarily “antagonistic toward the leadership,” said David Mericle, chief U.S. economist at Goldman Sachs. “It could actually be somewhat helpful, because they’re trying to get across ‘the bar is higher’ without saying, ‘We’re not going to do something that we might very well wind up wanting to do.’”

Trump’s own advisers have acknowledged the constraints in the past few days. Treasury Secretary Scott Bessent said recently that “the chair of the Federal Reserve has the ability to move and start the discussion, but at the end of the day, he or she has one vote.”

Kevin Hassett, a longtime Trump adviser and the presumed front-runner to succeed Powell, struck a similar note Tuesday. Asked what he would do if Trump publicly pressured him to cut rates, Hassett said his loyalty would be to his own judgment. “Suppose that inflation has gone from, say, 2.5% to 4%—you can’t cut rates then,” he said at The Wall Street Journal’s CEO Council Summit.

But the administration has also sent signals that suggest it might not quietly accept those limits.

Bessent has questioned the legitimacy of several regional Fed presidents who have been among the most hawkish voices, adding that they don’t hail from the districts whose banks they lead. He said he would advocate that future Fed presidents be required to have lived in their districts for at least three years—a rule that would have disqualified several sitting presidents. They are chosen by business and nonprofit leaders who sit on those banks’ boards of directors.

Trump has already tried to remove Lisa Cook, a Fed governor nominated by President Joe Biden who has successfully challenged her firing for now. The Supreme Court is set to hear arguments in her case in January, before the Fed’s next meeting.

Trump on Tuesday raised the far-fetched possibility of removing other Biden-nominated governors over how their nominations were signed—an indication of how eager he is to find any means, no matter how legally dubious, to reshape the committee.

The Trump administration’s efforts in recent months to challenge the institutional norms regarding the Fed are “like the raptors in the first ‘Jurassic Park’ movie testing the fences to see where the electricity was weak,” said Blake Gwinn, a rates strategist at RBC Capital Markets. “They’re trying different avenues…. The moat seems to have held up so far. I’m not saying it will forever.”

Yet for all the focus on who sits in the chair, the economy could ultimately decide the matter.

There is a reason the hawks have dug in. “We’ve had five consecutive years of missing the Fed’s inflation target on the high side,” Clarida said. “That’s a factor which weighs on people.” No new chair can change that.

On the other hand, the hawkish resistance that has defined recent meetings could melt away—not because of anything Trump or a new chair does, but because poor employment data leaves the committee little choice.

On Wednesday, Powell bluntly observed that recent employment reports have likely overstated tepid gains. After regular revisions to initial surveys are completed, job gains since April could be erased.

There are rumblings that the “slow to hire, slow to fire” job-market equilibrium over recent years might be shifting. Job growth apart from healthcare has been negative, on average, for the past six months, said Mericle, the Goldman economist.

“The challenging question is, What will the labor market in particular do?” he said. He hears from more executives that they or their peers are working on plans to cut back on staff. “There is a fair bit of chatter about layoffs,” he added.

Powell has three more meetings as chair before his successor takes over. By then, the data might force his hand—or leave the decision, unresolved, to whoever comes next. If the economy does open the door for the rate cuts Trump badly wants, there is a good chance it will do so by weakening in ways no president would welcome.

The Information : UAE Fund MGX Quietly Becomes One of the Biggest Data Center Fi

UAE Fund MGX Quietly Becomes One of the Biggest Data Center Financiers

The Takeaway
  • UAE fund MGX rapidly emerges as a leading global data center financier.
  • MGX secures largest stake in Aligned Data Centers’ $40 billion acquisition.
  • MGX invests in Vantage Data Centers, central to OpenAI’s Stargate project.

MGX, a United Arab Emirates–backed fund, is only a year old but has already become one of the biggest data center financiers in the world, leading the largest data center sale negotiated so far and quietly scooping up a stake in another provider with ties to OpenAI.

MGX will be the biggest shareholder in Aligned Data Centers, one of the largest data center operators in the U.S., following its $40 billion sale to an investor group, announced in October, according to a person familiar with the sale. At the same time, MGX last year acquired a minority stake in Vantage Data Centers, another big data center operator, which is central to OpenAI’s Stargate project, said people with knowledge of MGX’s data center activities.

The UAE has a long history of backing tech companies, both through its $330 billion sovereign wealth fund, Mubadala, and more recently through MGX, formed last year. In addition to its Aligned and Vantage stakes, MGX has invested in UAE-based Khazna Data Centers and struck deals to build data centers in France and Italy. The breadth and scale of MGX’s tech investments are a signal the country wants to become a dominant player in the development of powerful AI.

MGX is chaired by Sheikh Tahnoun bin Zayed Al Nahyan, a top national security official in the UAE, who has become a frequent presence in Silicon Valley. He met with President Donald Trump at the White House in March. The UAE afterward promised to invest $1.4 trillion in the U.S. over the next decade.

Much of that will likely go toward AI data centers, whose construction could require trillions of dollars in funding over the next few years, according to bank estimates.

BlackRock has said a partnership it formed with MGX could invest as much as $30 billion in data centers and power resources, an amount that would be boosted by $70 billion in borrowings. That suggests the companies could strike more deals following the Aligned acquisition.

BlackRock and MGX declined to comment on the specifics of the Aligned deal. Aligned and Vantage did not respond to requests for comment.

In Alignment

Aligned, which Macquarie Asset Management currently owns, operates data centers all over the U.S., in some cases on behalf of traditional cloud providers. The company had been considering an IPO before it struck the sale deal in October, according to the person familiar with the situation.

The Aligned buyers, identified as BlackRock, MGX and an investor group called the AI Infrastructure Partnership, together are paying about $21 billion for Aligned’s equity. Including its debt, the enterprise value put on the company will be about $40 billion. That will make the deal the largest data center transaction on record if its expected closing goes through in the first half of next year.

The breakdown of how much each investor owned wasn’t disclosed at the time the deal was announced. But a person with knowledge of it has since said MGX is purchasing 35% of Aligned’s equity, while BlackRock will purchase 20%.

AIP is buying the other 45%, said a person with knowledge of the deal. MGX owns the largest stake in AIP, although its investors also include Nvidia, Microsoft and BlackRock. That makes MGX the biggest investor in Aligned, while BlackRock will be the second biggest investor. The transaction hasn’t yet closed, and the details could still change.

MGX’s investment could trigger a review by the Committee on Foreign Investment in the United States, which typically looks at acquisitions handing control of a U.S. company in critical infrastructure to foreign investors.

It’s unclear whether MGX’s combined stake in Aligned would give it control of the company under CFIUS definitions. MGX shares control of AIP with BlackRock, said one person with knowledge of the partnership, suggesting it has a say in how AIP votes.

Meanwhile, MGX’s stake in Vantage has also given it a front-row seat to some of this year’s biggest data center deals. Vantage has borrowed a combined $38 billion for two data center campuses it’s building for Oracle, which is providing computing resources to OpenAI as part of the Stargate project. Ali Osman, MGX’s head of AI investments, joined the Vantage board of directors this year, said one person with knowledge of the investment.

The Information : Oracle’s Costly AI Expansion Turns Off Wall Street

Oracle’s Costly AI Expansion Turns Off Wall Street

The costs of Oracle’s AI data center expansion is becoming clear—and Wall Street isn’t happy. The software and cloud firm, which until recently was a solid moneymaker, said Wednesday it burned through $10 billion in cash in the November quarter thanks to a big ramp-up in capital expenditures on AI-focused data centers for its cloud business. Even more troubling for Wall Street: Oracle executives revealed on a conference call with analysts that this fiscal year’s capex would be 43% higher than the company projected last quarter, implying that the company would burn through much more cash in the full year than expected. Oracle shares fell as much as 11% in after-hours trading on Wednesday.

The fact that Oracle’s cloud revenues surged 68% in the quarter, meaningfully faster than in the past few quarters, didn’t seem to register with investors. Neither did Oracle’s revelation that it would generate $4 billion in additional revenue in fiscal 2027, starting in June, thanks to new cloud business it recently booked. That’s a meaningful lift given that analysts had projected fiscal 2027 revenue of $83 billion, according to S&P Global Market Intelligence. While investors last quarter cheered Oracle’s revelations that it had booked massive amounts of new cloud business, coming in through 2030, they’re now more focused on how Oracle will pay for the cost of bringing in that revenue.

Oracle co-CEO Clay Magouyrk tried to calm jitters, insisting that the company wouldn’t have to spend as much as analysts were projecting. He also said Oracle was considering ways of offering AI cloud services by leasing AI chips or by allowing customers to bring their own, both of which would reduce its capex. (He didn’t address whether that would also affect the revenue Oracle would get, but presumably that’s the trade-off.) But Magouyrk didn’t specifically answer a question from an analyst about how much money Oracle needs to raise for its data center expansion.

And investors aren’t just worried about costs. There’s also the uncertainty about whether the promised revenues in the 2029–30 time frame will materialize, given that Oracle’s future cloud business relies heavily on one customer in particular: OpenAI. No one knows whether the ChatGPT creator will need all the cloud commitments it has lined up with Oracle and others in the next few years—or whether it will be able to afford them. Oracle pointedly noted on Wednesday that it had recently struck deals with Nvidia, Meta Platforms and others to diversify its customer base. The company had previously announced deals with Nvidia and Meta, though, so news of those extra commitments may not be that reassuring. Oracle stock, after the 11% post-market slump, is now 39% lower than the high it reached in September. Investors will have to wait a while before Oracle stock once again trades at those September levels.

FT : Google DeepMind to build materials science lab after signing deal with UK

FT : Google DeepMind to build materials science lab after signing deal with UK

Google DeepMind will establish its first “automated science laboratory” in the UK, as it signs a new partnership with the British government in a move designed to enhance the use of artificial intelligence across the country.

The US Big tech group’s AI unit, run by British Nobel laureate Sir Demis Hassabis, announced on Thursday that it would set up the new materials science lab in 2026.

The lab will focus on using AI tools to develop new materials for superconductors, solar cells and semiconductors. DeepMind will also provide local scientists with “priority access” to its scientific AI tools.

“We think that AI systems are now ready to bridge the gap between digital and actually discovering new materials,” said Pushmeet Kohli, DeepMind’s vice-president for science and strategic initiatives.

DeepMind also signed a memorandum of understanding with the UK as Sir Keir Starmer’s government seeks to boost use of AI in science, education, public services and national security. 

The company, which was founded in London before being acquired by Google in 2014, has pledged to work more closely with the UK’s AI Security Institute (AISI) which evaluates and researches the safety of AI systems. 

DeepMind will offer access to its models to AISI researchers to jointly develop techniques to monitor an AI system’s chain-of-thought reasoning process, where the model solves problems step-by-step. It will also work with AISI to understand the social and emotional effect of its models on users, as well as the economic impacts of AI adoption. 

In return, the UK government will “explore” how teachers can use Google’s Gemini AI model for teaching England’s national curriculum. DeepMind will also offer technical expertise and access to its models to modernise public services.

“This partnership will make sure we harness developments in AI for public good so that everyone feels the benefits,” Starmer said.

“That means using AI to tackle everyday challenges like cutting energy bills thanks to cheaper, greener energy and making our public services more efficient so that taxpayers’ money is spent on what matters most to people.” 

The UK has also sought deals with AI companies to attract new investment into the country. It signed a technology pact with the US government to boost advances in science and AI research in September. 

AI models made by US-based Anthropic are being used to help citizens find UK government information. Meanwhile, Canada’s Cohere has pledged to also help the British public sector and defence industries use its technologies.

OpenAI has promised to “explore” developing research and development infrastructure in the UK, after setting up its first office outside the US in London two years ago.

Critics have argued that the UK is too close to Big Tech groups and should go further to regulate AI.

“We need to ask who is setting the agenda for the UK’s future with AI,” said Imogen Parker, associate director at the Ada Lovelace Institute, a research body.

“In the absence of independent regulation or scrutiny, we’re at the mercy of technology companies’ commercial interests aligning with what the public want.”

She added: “Google partnering with the government to explore how to refine its own Gemini model may or may not benefit teachers and pupils, but it will undoubtedly benefit Google.”